Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes

Jianya Huan, N. I. Hornick, N. A. Goloviznina, A. N. Kamimae-Lanning, Larry David, Phillip Wilmarth, Motomi (Tomi) Mori, J. R. Chevillet, A. Narla, Charles Roberts, Marc Loriaux, Bill Chang, Peter Kurre

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We recently demonstrated that acute myeloid leukemia (AML) cell lines and patient-derived blasts release exosomes that carry RNA and protein; following an in vitro transfer, AML exosomes produce proangiogenic changes in bystander cells. We reasoned that paracrine exosome trafficking may have a broader role in shaping the leukemic niche. In a series of in vitro studies and murine xenografts, we demonstrate that AML exosomes downregulate critical retention factors (Scf, Cxcl12) in stromal cells, leading to hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow. Exosome trafficking also regulates HSPC directly, and we demonstrate declining clonogenicity, loss of CXCR4 and c-Kit expression, and the consistent repression of several hematopoietic transcription factors, including c-Myb, Cebp-β and Hoxa-9. Additional experiments using a model of extramedullary AML or direct intrafemoral injection of purified exosomes reveal that the erosion of HSPC function can occur independent of direct cell–cell contact with leukemia cells. Finally, using a novel multiplex proteomics technique, we identified candidate pathways involved in the direct exosome-mediated modulation of HSPC function. In aggregate, this work suggests that AML exosomes participate in the suppression of residual hematopoietic function that precedes widespread leukemic invasion of the bone marrow directly and indirectly via stromal components.Leukemia advance online publication, 17 July 2015; doi:10.1038/leu.2015.163.

Original languageEnglish (US)
JournalLeukemia
DOIs
StateAccepted/In press - Jun 25 2015

Fingerprint

Exosomes
Hematopoietic Stem Cells
Acute Myeloid Leukemia
Bone Marrow
Exosome Multienzyme Ribonuclease Complex
Leukemia
Hematopoietic Stem Cell Mobilization
Myeloid Cells
Stromal Cells
Heterografts
Proteomics
Publications
Transcription Factors
Down-Regulation
Cell Line
Injections

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes. / Huan, Jianya; Hornick, N. I.; Goloviznina, N. A.; Kamimae-Lanning, A. N.; David, Larry; Wilmarth, Phillip; Mori, Motomi (Tomi); Chevillet, J. R.; Narla, A.; Roberts, Charles; Loriaux, Marc; Chang, Bill; Kurre, Peter.

In: Leukemia, 25.06.2015.

Research output: Contribution to journalArticle

@article{573614ecfcc3477eb442a13238f1f686,
title = "Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes",
abstract = "We recently demonstrated that acute myeloid leukemia (AML) cell lines and patient-derived blasts release exosomes that carry RNA and protein; following an in vitro transfer, AML exosomes produce proangiogenic changes in bystander cells. We reasoned that paracrine exosome trafficking may have a broader role in shaping the leukemic niche. In a series of in vitro studies and murine xenografts, we demonstrate that AML exosomes downregulate critical retention factors (Scf, Cxcl12) in stromal cells, leading to hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow. Exosome trafficking also regulates HSPC directly, and we demonstrate declining clonogenicity, loss of CXCR4 and c-Kit expression, and the consistent repression of several hematopoietic transcription factors, including c-Myb, Cebp-β and Hoxa-9. Additional experiments using a model of extramedullary AML or direct intrafemoral injection of purified exosomes reveal that the erosion of HSPC function can occur independent of direct cell–cell contact with leukemia cells. Finally, using a novel multiplex proteomics technique, we identified candidate pathways involved in the direct exosome-mediated modulation of HSPC function. In aggregate, this work suggests that AML exosomes participate in the suppression of residual hematopoietic function that precedes widespread leukemic invasion of the bone marrow directly and indirectly via stromal components.Leukemia advance online publication, 17 July 2015; doi:10.1038/leu.2015.163.",
author = "Jianya Huan and Hornick, {N. I.} and Goloviznina, {N. A.} and Kamimae-Lanning, {A. N.} and Larry David and Phillip Wilmarth and Mori, {Motomi (Tomi)} and Chevillet, {J. R.} and A. Narla and Charles Roberts and Marc Loriaux and Bill Chang and Peter Kurre",
year = "2015",
month = "6",
day = "25",
doi = "10.1038/leu.2015.163",
language = "English (US)",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes

AU - Huan, Jianya

AU - Hornick, N. I.

AU - Goloviznina, N. A.

AU - Kamimae-Lanning, A. N.

AU - David, Larry

AU - Wilmarth, Phillip

AU - Mori, Motomi (Tomi)

AU - Chevillet, J. R.

AU - Narla, A.

AU - Roberts, Charles

AU - Loriaux, Marc

AU - Chang, Bill

AU - Kurre, Peter

PY - 2015/6/25

Y1 - 2015/6/25

N2 - We recently demonstrated that acute myeloid leukemia (AML) cell lines and patient-derived blasts release exosomes that carry RNA and protein; following an in vitro transfer, AML exosomes produce proangiogenic changes in bystander cells. We reasoned that paracrine exosome trafficking may have a broader role in shaping the leukemic niche. In a series of in vitro studies and murine xenografts, we demonstrate that AML exosomes downregulate critical retention factors (Scf, Cxcl12) in stromal cells, leading to hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow. Exosome trafficking also regulates HSPC directly, and we demonstrate declining clonogenicity, loss of CXCR4 and c-Kit expression, and the consistent repression of several hematopoietic transcription factors, including c-Myb, Cebp-β and Hoxa-9. Additional experiments using a model of extramedullary AML or direct intrafemoral injection of purified exosomes reveal that the erosion of HSPC function can occur independent of direct cell–cell contact with leukemia cells. Finally, using a novel multiplex proteomics technique, we identified candidate pathways involved in the direct exosome-mediated modulation of HSPC function. In aggregate, this work suggests that AML exosomes participate in the suppression of residual hematopoietic function that precedes widespread leukemic invasion of the bone marrow directly and indirectly via stromal components.Leukemia advance online publication, 17 July 2015; doi:10.1038/leu.2015.163.

AB - We recently demonstrated that acute myeloid leukemia (AML) cell lines and patient-derived blasts release exosomes that carry RNA and protein; following an in vitro transfer, AML exosomes produce proangiogenic changes in bystander cells. We reasoned that paracrine exosome trafficking may have a broader role in shaping the leukemic niche. In a series of in vitro studies and murine xenografts, we demonstrate that AML exosomes downregulate critical retention factors (Scf, Cxcl12) in stromal cells, leading to hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow. Exosome trafficking also regulates HSPC directly, and we demonstrate declining clonogenicity, loss of CXCR4 and c-Kit expression, and the consistent repression of several hematopoietic transcription factors, including c-Myb, Cebp-β and Hoxa-9. Additional experiments using a model of extramedullary AML or direct intrafemoral injection of purified exosomes reveal that the erosion of HSPC function can occur independent of direct cell–cell contact with leukemia cells. Finally, using a novel multiplex proteomics technique, we identified candidate pathways involved in the direct exosome-mediated modulation of HSPC function. In aggregate, this work suggests that AML exosomes participate in the suppression of residual hematopoietic function that precedes widespread leukemic invasion of the bone marrow directly and indirectly via stromal components.Leukemia advance online publication, 17 July 2015; doi:10.1038/leu.2015.163.

UR - http://www.scopus.com/inward/record.url?scp=84937250017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937250017&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.163

DO - 10.1038/leu.2015.163

M3 - Article

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -